Literature DB >> 6415734

Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems.

S T Mason, A Angel.   

Abstract

A behavioral system sensitive to the net functional activity of the locus coeruleus noradrenergic system, with characteristics of a beta-adrenoceptor mediated response, has been developed based on the duration of thiopentone anaesthesia in the rat. The effects of acute and chronic treatment with the tricyclic antidepressant desipramine (DMI) were determined. Acute DMI from 5 to 25 mg/kg increased thiopentone sleeping-time in a dose-dependent fashion. This was due to an action on noradrenergic systems, since it was mimicked by treatment with the selective neurotoxin 6-hydroxydopamine, which itself increased thiopentone sleeping-time and prevented any additional effect of DMI. Chronic treatment with DMI had no effect on thiopentone sleeping-time when carried out for 2 or 5 days but markedly prolonged it when carried out for 10 or 20 days, thus paralleling the time course of clinical action of the drug.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415734     DOI: 10.1007/BF00439277

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons.

Authors:  H V Nybäck; J R Walters; G K Aghajanian; R H Roth
Journal:  Eur J Pharmacol       Date:  1975 Jun-Jul       Impact factor: 4.432

2.  Development of beta-adrenergic receptor subsensitivity by antidepressants.

Authors:  S P Banerjee; L S Kung; S J Riggi; S K Chanda
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

3.  Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain.

Authors:  D C U'Prichard; D A Greenberg; P P Sheehan; S H Snyder
Journal:  Science       Date:  1978-01-13       Impact factor: 47.728

Review 4.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

5.  Cortical neurone responsiveness to substance P is enhanced following chronic but not acute administration of desipramine.

Authors:  R S Jones; H R Olpe
Journal:  Eur J Pharmacol       Date:  1983-01-28       Impact factor: 4.432

6.  Brain histamine receptors as targets for antidepressant drugs.

Authors:  P D Kanof; P Greengard
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

7.  Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.

Authors:  M Nielsen; C Braestrup
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

8.  Long-lasting peripheral and central effects of 6-hydroxydopamine in rats.

Authors:  D W Clark; R Laverty; E L Phelan
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

9.  Tricyclic antidepressants vary in decreasing alpha 2-adrenoceptor sensitivity with chronic treatment: assessment with clonidine inhibition of acoustic startle.

Authors:  M Davis; D B Menkes
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

10.  Differential effect of chronic desipramine and amitriptyline treatment on rat brain adrenergic and serotonergic receptors.

Authors:  S W Tang; P Seeman; S Kwan
Journal:  Psychiatry Res       Date:  1981-04       Impact factor: 3.222

View more
  3 in total

1.  Chronic and acute administration of typical and atypical antidepressants on activity of brain noradrenaline systems in the rat thiopentone anaesthesia model.

Authors:  S T Mason; A Angel
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Hypnotic hypersensitivity to volatile anesthetics and dexmedetomidine in dopamine β-hydroxylase knockout mice.

Authors:  Frances Y Hu; George M Hanna; Wei Han; Feras Mardini; Steven A Thomas; Abraham J Wyner; Max B Kelz
Journal:  Anesthesiology       Date:  2012-11       Impact factor: 7.892

Review 3.  Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.

Authors:  N P Nair; S K Ahmed; N M Kin
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.